| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 82,561 | 83,755 | 77,870 | 73,452 | | Cost of Revenue | 42,318 | 43,082 | 41,111 | 38,094 | | | Gross Profit | 40,243 | 40,673 | 36,759 | 35,358 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,963 | 13,924 | 13,183 | 12,621 | | Non Recurring | 30,203 |
-
| 58,807 |
-
| | Others | (14,639) | 15,443 | (43,492) | 15,318 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,716 | 11,306 | 8,261 | 7,419 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 10,716 | 11,306 | 8,261 | 7,419 | | Interest Expense | 776 | 247 | 521 | 1,683 | | Income Before Tax | 9,940 | 11,059 | 7,740 | 5,736 | | Income Tax Expense | 3,628 | 4,031 | 2,622 | 2,100 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,312 | 7,028 | 5,118 | 3,636 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,312 | 7,028 | 5,118 | 3,636 | | Preferred Stock And Other Adjustments | (10) | (10) |
-
|
-
| | | Net Income Applicable To Common Shares | $6,302 | $7,018 | $5,118 | $3,636 |
|
0.51% Nasdaq 
Income Statement
